Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. - Wikidata - awgldk - TriplyDB

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.

http://www.wikidata.org/entity/Q33438465

about

The ageing systemic milieu negatively regulates neurogenesis and cognitive function.Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults.Homeostatic disinhibition in the aging brain and Alzheimer's disease Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle.PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT The aging hippocampus: interactions between exercise, depression, and BDNF Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Neuronal and cognitive plasticity: a neurocognitive framework for ameliorating cognitive aging.Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease Synaptic therapy in Alzheimer's disease: a CREB-centric approach.The associations between serum brain-derived neurotrophic factor, potential confounders, and cognitive decline: a longitudinal study.Stem cell technology for neurodegenerative diseases.Chotosan (Diaoteng San)-induced improvement of cognitive deficits in senescence-accelerated mouse (SAMP8) involves the amelioration of angiogenic/neurotrophic factors and neuroplasticity systems in the brain.Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.Plasma BDNF levels associate with Pittsburgh compound B binding in the brain Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease Overexpression of brain-derived neurotrophic factor in the hippocampus protects against post-stroke depression.Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration A Lack of Correlation between Brain-Derived Neurotrophic Factor Serum Level and Verbal Memory Performance in Healthy Polish Population.Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase.Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease.Neurocognitive Aging and the Hippocampus across Species.Progress in stem cell therapy for major human neurological disorders.Probing the mechanisms underlying the mitigation of cognitive aging with anodal transcranial direct current stimulation.Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.Phospholipid transfer protein (PLTP) deficiency accelerates memory dysfunction through altering amyloid precursor protein (APP) processing in a mouse model of Alzheimer's disease.Task demands, tDCS intensity, and the COMT val158met polymorphism impact tDCS-linked working memory training gains.Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma.Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.

P2860

Q24599219-07A7FD31-C1C7-48F3-85D5-68662C1034E2 Q26785375-122105AD-2794-47AE-B11D-EF1799061DA9 Q27315300-7BD46660-96FC-404F-8A27-631CFF197925 Q30468413-72E20B45-F50E-4C24-963C-D3C97D43BF04 Q33780879-4C0F2F90-8203-4437-9904-461118BB96C6 Q33817811-F7588519-49D4-46DB-9B75-4AB0C2392989 Q33818120-7053F711-1184-4030-8AB1-E14181F2D3DE Q34181430-3F4F3999-72BD-412B-94B4-684CCF377AFF Q34277859-854FD277-73BD-4AF0-88BB-A05CF4474582 Q34394701-21F1C525-87DC-47AD-B3F4-5249B017847C Q34516825-279C8ACB-B0AE-4C9B-B4A8-5832A4A2B020 Q34547754-A8970C87-45D6-4723-B51B-7E291376E8DE Q35064948-D2802F18-CFFB-438E-906B-C5FBD43DFB98 Q35131964-8E79374B-DED2-4718-8279-370E1A8A3F44 Q35224202-CCAC73C9-263A-485D-9F3D-C3C6123C312B Q35290483-E00D6B66-116D-4726-9823-C107DBA98C3E Q35497573-8A20B2CC-E1C0-416C-A64A-BA59F24C5C0C Q35865843-58605860-3FC2-4885-9098-0929F497ADD4 Q35929042-66C98BF7-32FC-4C03-B0B1-1A35DAC602E5 Q35967384-B9303FCC-3F31-4D65-A07E-264F51D83E50 Q36222787-A9FA10B8-A92F-42E6-B276-90CFD42ECA03 Q36851799-3225B033-19F7-4614-8446-ADABAA10C8D9 Q36924560-634BA9BE-6062-40A2-B727-639006C95EE3 Q36943048-28BDB098-24FA-43B5-95AE-B734014561C1 Q36997320-5BDE71D6-7EC5-4908-A612-F5F6575D3747 Q37050580-05FC6955-1041-469E-822F-7743A7554048 Q37062425-2464E320-6871-48EC-B726-728473E35C23 Q37357741-879CAD14-D44B-4F3D-831D-6608B80AF624 Q37562884-4E1DC1C1-FCBF-4476-BC18-F42DCB47AB48 Q37568735-CF9EDD25-3C74-4FE0-BCA1-A1F31877934E Q38107439-501C8DA9-46C2-4F48-BE4B-0E6369DA87A9 Q38171015-1B82B0EC-D290-4F53-85E3-FC222208B4BD Q38263685-D244641B-2D86-47BC-AC2F-D066A3961009 Q38979999-BED28DAF-9E6E-4F97-8D6E-6682392F497D Q38988833-09FC4743-E0BA-4728-A333-AD0F827ABCC7 Q40752006-DBF54250-F953-4A2C-92F3-4168CFAEFC17 Q42677484-B9E7000F-4545-4570-9D62-083F389BDB6A Q44669549-E16563EE-DCF3-41F6-A2D9-4F64B1E97B14 Q45300839-7C0401D7-5BE1-4F61-863A-63CB6371EE4C Q47134578-B23ADE85-8345-4DFC-BAB4-96E6D330ECE0

P2860

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.

http://www.wikidata.org/entity/Q33438465

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@ast

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@en

type

label

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@ast

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@en

prefLabel

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@ast

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@en

P1433

Q33438465-8CBCC979-5C43-4E97-AB5B-780AB09CDFD9

P1476

Q33438465-A75F52E9-F338-4B59-A319-7B0D49E7D885

P2093

Q33438465-0F749391-9043-4FE3-A872-913FA79A2C1F

Q33438465-142BA3B9-DE16-4FC1-908F-D9846409D417

Q33438465-5AE04D9B-AAB7-4ABA-9A16-353EA28E12B5

Q33438465-6FA1999B-7FC9-45EC-9C42-65D0614C470E

Q33438465-82BA931B-826A-4F93-8D8D-FB930876D957

Q33438465-B132C79C-0417-4B63-909F-6DA2DD0F5D49

Q33438465-B5A7D6B3-F2D7-4D19-8465-E1479762F254

Q33438465-C2CCF843-C5A7-4436-A41A-A0B3A74F37EF

Q33438465-C937CDDA-AE3E-4ADA-9B3C-0A09502F479A

Q33438465-E85AF40D-F9FE-4137-8AEA-823E534205A9

P2860

Q33438465-09F5121C-6D2F-4630-9E06-03EDF73A6FA2

Q33438465-17C50CCA-C666-43F6-BA00-57A37730A6A9

Q33438465-2979A5E9-D3BF-4E98-892C-EBEF209AAEB3

Q33438465-3C3D4F69-BE28-4ABA-83A5-DEB5CFB5EED3

Q33438465-4B5CB677-4D90-46CE-89C4-98241E5DFB91

Q33438465-5115CD29-8C2B-4B75-AB67-D621F36690CD

Q33438465-5845BA31-4239-48E9-9B31-68172B1EC1DC

Q33438465-623891AD-6261-4E2F-8664-FCC693432E52

Q33438465-671E5918-2484-48B2-BC05-3508EB87EFE4

Q33438465-68B8573D-2115-40A8-8588-93639FC25440

P304

Q33438465-A0D243FD-7EFC-4025-AB91-0190C847BFF0

P31

Q33438465-9F72EAE5-F72E-45F0-BA36-B2DC43DA806C

P356

Q33438465-6A2D4D03-C046-4ECA-AAFE-F43761F18097

P407

Q33438465-BDDFF8B8-176C-48C4-A30A-A14D77064182

P433

Q33438465-6AF695DD-DAF3-46DD-B524-458E92490CEB

P478

Q33438465-6D03A809-0FC4-4175-8382-EFD06334E468

P577

Q33438465-04A09892-6527-4ADE-8E7A-F134D6F63F57

P5875

Q33438465-55E1BB1B-91A3-4580-A2CB-A156997ABBAB

P698

Q33438465-0BB2D773-F448-4E53-B004-20F0DD722068

P921

Q33438465-E840422F-3E54-45ED-A67D-B923982E3A60

P932

Q33438465-7D7D9D37-A920-4E0C-88E2-34E4224BEC46

P356

JOURNAL.PONE.0005424

P1433

P1476

Cerebrospinal fluid concentrat ...... tion in non-demented subjects.

@en

P2093

Chang-En Yu

http://www.w3.org/2001/XMLSchema#string

Douglas R Galasko

http://www.w3.org/2001/XMLSchema#string

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Ge Li

http://www.w3.org/2001/XMLSchema#string

Izabela Sokal

http://www.w3.org/2001/XMLSchema#string

Lynn M Bekris

http://www.w3.org/2001/XMLSchema#string

Murray A Raskind

http://www.w3.org/2001/XMLSchema#string

Peter Chi

http://www.w3.org/2001/XMLSchema#string

Steven P Millard

http://www.w3.org/2001/XMLSchema#string

Thomas J Montine

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note.

Changes in cytokines and neurotrophins in Parkinson's disease.

Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.

Estrogen-BDNF interactions: implications for neurodegenerative diseases.

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

Using verbal fluency to detect very mild dementia of the Alzheimer type.

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

P304

e5424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0005424

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24398968

http://www.w3.org/2001/XMLSchema#string

P698

19412541

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

2671606

http://www.w3.org/2001/XMLSchema#string